The Role of Inflammation in Myocardial Infarction (NCT06065514) | Clinical Trial Compass
CompletedNot Applicable
The Role of Inflammation in Myocardial Infarction
Cyprus, Greece100 participantsStarted 2023-08-24
Plain-language summary
The aim of this research is to study the prognostic role of a selected combination of cytokines and adipokines in patients with myocardial infarction, as well as to determine their role in the development of adverse cardiac remodeling.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. ACS (ST-ACS, NSTE-ACS, UA) referred for coronary angiography
. Above 18 years old
. Consent form obtained
Exclusion criteria
. Chronic Renal Failure (CRF) stage IV (e GFR \< 29 ml/min or creatinine \> 2 mg/dl)
. Chronic Liver Disease (CLD) (ALT \> 2 times upper normal limit)
. Chronic Inflammation and/or autoimmune diseases
. Active Ca
. Recent CVA (less than 1 month)
. Recent (within 2 weeks) use of glucocorticoid drugs or immunosuppressive agents
. Acute or chronic infection, major surgery, or trauma in the last month
. Previous heart transplantation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied the role of inflammation in heart attacks and measured mortality rates — what did researchers find, and could those findings change how my own heart attack risk or recovery might be managed?
2Since this trial has already been completed, has the data been published anywhere, and would my doctor be able to review the results with me to see if they're relevant to my situation?
3The trial focused on inflammation as a factor in heart attacks — based on what's known so far, are there any anti-inflammatory treatments or monitoring approaches my doctor thinks might be worth considering for me?
4Because this was listed as 'Phase NA,' it sounds more like an observational or data-collection study rather than a drug trial — does that mean it was looking at existing patients rather than testing a new treatment, and how does that affect how useful the findings are for someone in my position?
5Given that mortality was the primary outcome being tracked, what does my doctor think this kind of research tells us about the most dangerous phases after a heart attack, and are there warning signs I should be watching for??
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.